Gerald Boudreaux, D-Lafayette, would require the Louisiana Department of Health to provide coverage for FDA-approved weight loss medications, including GLP-1s that are medically necessary. GLP-1 medication, both the shots and pills, for the states Medicaid patients is currently covered for those with a certain level of obesity and "co-occurring conditions" (such as Type 2 diabetes, sleep apnea and congestive heart failure)
The upregulation of NRF2 and SOD1, along with the activation of ROS scavenging pathways, can lead to resistance to chemotherapy or targeted therapy in various tumors
16: Friday afternoon, the FDA announced one of 2024s most-anticipated approvals: that of Iovance Biotherapeutics lifileucel for advanced melanoma
(2025) Zepbound (Tirzepatide) injection (2025) Ania M
If unsure about the severity, contact NHS 111 for advice